{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:15:22Z","timestamp":1790946922710,"version":"4.1.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Dyslipidemia secondary to obesity is a risk factor related to cardiovascular disease events, however a pathological conventional lipid profile (CLP) is infrequently found in obese children. The objective is to evaluate the advanced lipoprotein testing (ALT) and its relationship with cardiac changes, metabolic syndrome (MS) and inflammatory markers in a population of morbidly obese adolescents with normal CLP and without type 2 diabetes mellitus, the most common scenario in obese adolescents.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Prospective case-control research of 42 morbidly obese adolescents and 25 normal-weight adolescents, whose left ventricle (LV) morphology and function had been assessed. The ALT was obtained by proton nuclear magnetic resonance spectroscopy, and the results were compared according to the degree of cardiac involvement \u2013 normal heart, mild LV changes, and severe LV changes (specifically LV remodeling and systolic dysfunction) \u2013 and related to inflammation markers [highly-sensitive C-reactive protein and glycoprotein A (GlycA)] and insulin-resistance [homeostatic model assessment for insulin-resistance (HOMA-IR)]. A second analysis was performed to compare our results with the predominant ALT when only body mass index and metabolic syndrome criteria were considered.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The three cardiac involvement groups showed significant increases in HOMA-IR, inflammatory markers and ALT ratio LDL-P\/HDL-P (40.0 vs. 43.9 vs. 47.1, <jats:italic>p<\/jats:italic> 0.012). When only cardiac change groups were considered, differences in small LDL-P (565.0 vs. 625.1\u2005nmol\/L, <jats:italic>p<\/jats:italic> 0.070), VLDL size and GlycA demonstrated better utility than just traditional risk factors to predict which subjects could present severe LV changes [AUC: 0.79 (95% CI: 0.54\u20131)]. In the second analysis, an atherosclerotic ALT was detected in morbidly obese subjects, characterized by a significant increase in large VLDL-P, small LDL-P, ratio LDL-P\/HDL-P and ratio HDL-TG\/HDL-C. Subjects with criteria for MS presented overall worse ALT (specially in triglyceride-enriched particles) and remnant cholesterol values.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>ALT parameters and GlycA appear to be more reliable indicators of cardiac change severity than traditional CV risk factors. Particularly, the overage of LDL-P compared to HDL-P and the increase in small LDL-P with cholesterol-depleted LDL particles appear to be the key ALT's parameters involved in LV changes. Morbidly obese adolescents show an atherosclerotic ALT and those with MS present worse ALT values.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2022.887771","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T08:39:01Z","timestamp":1669106341000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Different profiles of lipoprotein particles associate various degrees of cardiac involvement in adolescents with morbid obesity"],"prefix":"10.3389","volume":"10","author":[{"given":"Jos\u00e9 M.","family":"Siurana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sabat\u00e9-Rot\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Amig\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neus","family":"Mart\u00ednez-Micaelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Arciniegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Riaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Mogas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Ros\u00e9s-Noguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula S.","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Yeste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"B1","year":""},{"key":"B2","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European atherosclerosis society consensus panel","volume":"41","author":"Bor\u00e9n","year":"2020","journal-title":"Eur Heart J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1161\/CIRCRESAHA.116.304846","article-title":"Remnant cholesterol, low-density lipoprotein cholesterol, and blood pressure as mediators from obesity to ischemic heart disease","volume":"116","author":"Varbo","year":"2015","journal-title":"Circ Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1373\/clinchem.2017.279463","article-title":"Remnant cholesterol and myocardial infarction in Normal weight, overweight, and obese individuals from the Copenhagen general population study","volume":"64","author":"Varbo","year":"2018","journal-title":"Clin Chem"},{"key":"B6","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jacl.2007.10.001","article-title":"LDL Particle number and risk of future cardiovascular disease in the framingham offspring study - implications for LDL management","volume":"1","author":"Cromwell","year":"2007","journal-title":"J Clin Lipidol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jacl.2011.07.005","article-title":"Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists","volume":"5","author":"Davidson","year":"2011","journal-title":"J Clin Lipidol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.3390\/ijms20133151","article-title":"HDL Triglycerides: a new marker of metabolic and cardiovascular risk","volume":"20","author":"Girona","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3390\/jcm10071379","article-title":"Physicochemical properties of lipoproteins assessed by nuclear magnetic resonance as a predictor of premature cardiovascular disease. PRESARV-SEA study","volume":"10","author":"Fern\u00e1ndez-Cid\u00f3n","year":"2021","journal-title":"J Clin Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ijcard.2018.03.128","article-title":"LDL Particle size and composition and incident cardiovascular disease in a south-European population: the hortega-liposcale follow-up study","volume":"264","author":"Pichler","year":"2018","journal-title":"Int J Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1161\/CIRCULATIONAHA.113.005873","article-title":"Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events","volume":"129","author":"Mora","year":"2014","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.amjcard.2016.03.040","article-title":"Discordance of low-density lipoprotein and high-density lipoprotein cholesterol particle versus cholesterol concentration for the prediction of cardiovascular disease in patients with metabolic syndrome and diabetes Mellitus (from the multi-ethnic study of atherosclerosis [MESA])","volume":"117","author":"Tehrani","year":"2016","journal-title":"Am J Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.jacl.2017.05.011","article-title":"Lipoprotein particle number and size predict vascular structure and function better than traditional lipids in adolescents and young adults","volume":"11","author":"Urbina","year":"2017","journal-title":"J Clin Lipidol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.bbacli.2015.03.005","article-title":"Lipoprotein particles and size, total and high molecular weight adiponectin, and leptin in relation to incident coronary heart disease among severely obese postmenopausal women: the women's health initiative observational study","volume":"3","author":"Mackey","year":"2015","journal-title":"BBA Clin"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1161\/CIRCULATIONAHA.115.016857","article-title":"Atherogenic lipoprotein subfractions determined by Ion mobility and first cardiovascular events after random allocation to high-intensity statin or placebo: the justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER) trial","volume":"132","author":"Mora","year":"2015","journal-title":"Circulation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.amjcard.2021.07.026","article-title":"Myocardial geometry and dysfunction in morbidly obese adolescents (BMI 35\u201340\u2005kg\/m2)","volume":"157","author":"Siurana","year":"2021","journal-title":"Am J Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.anpedi.2017.12.016","article-title":"Body mass index and tri-ponderal mass index of 1,453 healthy non-obese, non-undernourished millennial children. The Barcelona longitudinal growth study","volume":"89","author":"Carrascosa","year":"2018","journal-title":"An Pediatr (Engl Ed)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1001\/archpedi.157.8.821","article-title":"Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third national health and nutrition examination survey, 1988\u20131994","volume":"157","author":"Cook","year":"2003","journal-title":"Arch Pediatr Adolesc Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1097\/HJH.0000000000001039","article-title":"2016 European society of hypertension guidelines for the management of high blood pressure in children and adolescents","volume":"34","author":"Lurbe","year":"2016","journal-title":"J Hypertens"},{"key":"B20","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1194\/jlr.D050120","article-title":"Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy","volume":"56","author":"Mallol","year":"2015","journal-title":"J Lipid Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2337\/dc16-1569","article-title":"Novel protein glycan-derived markers of systemic inflammation and C-reactive protein in relation to glycemia, insulin resistance, and insulin secretion","volume":"40","author":"Lorenzo","year":"2017","journal-title":"Diabetes Care"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1021\/acs.jproteome.9b00528","article-title":"Glycoprotein A and B height-to-width ratios as obesity-independent novel biomarkers of low-grade chronic inflammation in women with polycystic ovary syndrome (PCOS)","volume":"18","author":"Fuertes-Mart\u00edn","year":"2019","journal-title":"J Proteome Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3390\/life11121407","article-title":"Glycoprotein profile measured by a 1H-nuclear magnetic resonance based on approach in patients with diabetes: a new robust method to assess inflammation","volume":"11","author":"Amig\u00f3","year":"2021","journal-title":"Life (Basel)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2021.06.905","article-title":"Serum glycoproteins A and B assessed by 1H-NMR in familial hypercholesterolemia","volume":"330","author":"Malo","year":"2021","journal-title":"Atherosclerosis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification: a report from the American society of echocardiography\u2019s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European society of cardiology","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"B26","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.echo.2009.03.003","article-title":"Age-specific reference intervals for indexed left ventricular mass in children","volume":"22","author":"Khoury","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1161\/01.CIR.97.19.1907","article-title":"Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension","volume":"97","author":"Daniels","year":"1998","journal-title":"Circulation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.echo.2014.11.003","article-title":"Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI\/ASE\/industry task force to standardize deformation imaging","volume":"28","author":"Voigt","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"B29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.echo.2015.11.016","article-title":"Reference ranges of left ventricular strain measures by two-dimensional speckle-tracking echocardiography in children: a systematic review and meta-analysis","volume":"29","author":"Levy","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"B30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.recesp.2021.02.013","article-title":"Advanced lipoprotein profile in individuals with normal and impaired glucose metabolism","volume":"75","author":"Puig-Jov\u00e9","year":"2022","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.jacl.2016.01.007","article-title":"Superiority of lipoprotein particle number to detect associations with arterial thickness and stiffness in obese youth with and without prediabetes","volume":"10","author":"Shah","year":"2016","journal-title":"J Clin Lipidol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1210\/clinem\/dgz261","article-title":"Postprandial dyslipidemia, hyperinsulinemia, and impaired gut peptides\/bile acids in adolescents with obesity","volume":"105","author":"Higgins","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jpeds.2013.01.012","article-title":"Low-density lipoprotein cholesterol versus particle number in middle school children","volume":"163","author":"Mietus-Snyder","year":"2013","journal-title":"J Pediatr"},{"key":"B34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0021-9150(98)00037-9","article-title":"The atherogenic lipoprotein phenotype and vascular endothelial dysfunction","volume":"138","author":"Sattar","year":"1998","journal-title":"Atherosclerosis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/ATVBAHA.114.303284","article-title":"Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the atherosclerosis risk in communities (ARIC) study","volume":"34","author":"Hoogeveen","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"628","DOI":"10.2337\/dc14-0645","article-title":"Lipoprotein particles and incident type 2 diabetes in the multi-ethnic study of atherosclerosis","volume":"38","author":"Mackey","year":"2015","journal-title":"Diabetes Care"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1161\/ATVBAHA.111.241463","article-title":"Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia","volume":"32","author":"Sparks","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1194\/jlr.R039297","article-title":"Cardioprotective functions of HDLs","volume":"55","author":"Rye","year":"2014","journal-title":"J Lipid Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1161\/CIRCRESAHA.108.180638","article-title":"When HDL gets fat","volume":"103","author":"Brown","year":"2008","journal-title":"Circ Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.arteri.2020.04.004","article-title":"Consensus document of an expert group from the spanish society of arteriosclerosis (SEA) on the clinical use of nuclear magnetic resonance to assess lipoprotein metabolism (liposcale\u00ae)","volume":"32","author":"Pint\u00f3","year":"2020","journal-title":"Clin Investig Arterioscler"},{"key":"B42","doi-asserted-by":"publisher","first-page":"19249","DOI":"10.1038\/srep19249","article-title":"Lipoprotein hydrophobic core lipids are partially extruded to surface in smaller HDL: \u201cherniated\u201d HDL, a common feature in diabetes","volume":"6","author":"Amig\u00f3","year":"2016","journal-title":"Sci Rep"},{"key":"B43","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00125-004-1655-5","article-title":"Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia","volume":"48","author":"Nob\u00e9court","year":"2005","journal-title":"Diabetologia"},{"key":"B44","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2016.02.014","article-title":"Nuclear magnetic resonance lipoprotein abnormalities in newly-diagnosed type 2 diabetes and their association with preclinical carotid atherosclerosis","volume":"247","author":"Amor","year":"2016","journal-title":"Atherosclerosis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.113.002671","article-title":"High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy","volume":"128","author":"Mora","year":"2013","journal-title":"Circulation"},{"key":"B46","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jacc.2017.12.006","article-title":"Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke","volume":"71","author":"Holmes","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1194\/jlr.M078667","article-title":"Obesity is associated with an altered HDL subspecies profile among adolescents with metabolic disease","volume":"58","author":"Davidson","year":"2017","journal-title":"J Lipid Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1161\/CIRCULATIONAHA.118.035432","article-title":"Lipoprotein particle profiles, standard lipids, and peripheral artery disease incidence","volume":"138","author":"Aday","year":"2018","journal-title":"Circulation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","author":"Varbo","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.echo.2010.08.010","article-title":"Accuracy and reproducibility of strain by speckle tracking in pediatric subjects with normal heart and single ventricular physiology: a two-dimensional speckle-tracking echocardiography and magnetic resonance imaging correlative study","volume":"23","author":"Singh","year":"2010","journal-title":"J Am Soc Echocardiogr"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.887771\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T08:39:04Z","timestamp":1669106344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.887771\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":50,"alternative-id":["10.3389\/fped.2022.887771"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.887771","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"article-number":"887771"}}